Picture of Biosynex SA logo

ALBIO Biosynex SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapTurnaround

Brief: Biosynex Reinforces Production Capacities In France

May 7 (Reuters) - Biosynex SA  ALBIO.PA :
    * REINFORCEMENT OF PRODUCTION CAPACITIES IN FRANCE
    * FIRM ORDERS FOR 4.5 MILLION COVID-19 BSS RAPID SEROLOGICAL
TESTS
    * PLANS TO INVEST MORE THAN 2 M€ IN A PRODUCTION AUTOMATION
TOOL
AND IN THE EXTENSION OF THE CURRENT PREMISES
    * OTHER FIRM INTERNATIONAL ORDERS HAVE BEEN REGISTERED AND
MANY
MORE ARE BEING CONFIRMED FOR DELIVERY SCHEDULED FOR JUNE 2020
    * WILL START MARKETING THE LIFERIVER PCR KIT IN THE SECOND
HALF OF
MAY, WHICH IS APPROVED AND HAS OBTAINED CE MARK
    * INSTALLATION OF THESE COVID-19 LIFERIVER PCR TEST KITS
WILL
ALLOW ANALYTICAL LABORATORIES TO WORK IN SERIES AND ENSURE MORE
THAN 1,000 TESTS / DAY PER SITE

Source text for Eikon:  ID:nBw82bfSYa 
Further company coverage:  ALBIO.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))

Recent news on Biosynex SA

See all news